Erivedge, a new anti-cancer drug from Genentech was approved at the end of January.  Assistance programs include co-pay assistance for insured patients as well as free access for qualified uninsured and denied coverage patients.  The drug is delivered only through specialty pharmacies directly to the patient.  A link for more information is here.